Speciality Medicines IPO Subscription Status
Speciality Medicines IPO received bids for 73,31,000 shares against 32,89,000 offered, an overall subscription of 2.23x at the close of bidding (24 Mar 2026). QIBs lead at 96.24x, while Retail (0.85x) portion is undersubscribed.
Last updated · day 3 figures
- Retail
- 0.85x
- NII
- 2.01x
- QIB
- 96.24x
- Total
- 2.23x
Speciality Medicines IPO allotment chances
Approximate · day 3- Retail / Individual 0.85x
- 1 in 1 Fewer applications than lots
- Based on applications vs lots
- sNII ₹2–10 lakh 0.64x
- 1 in 1 Fewer applications than lots
- Based on applications vs lots
- bNII Above ₹10 lakh 2.70x
- 1 in 1 Fewer applications than lots
- Based on applications vs lots
Where the demand is
Speciality Medicines IPO subscription by category
| Category | Shares offered | Shares bid | Amount bid | Subscription |
|---|---|---|---|---|
| QIB | 21,000 | 20,21,000 | ₹25.06 Cr | 96.24x |
| NII | 10,89,000 | 21,94,000 | ₹27.21 Cr | 2.01x |
| bNII above ₹10 lakh | 7,26,000 | 19,63,000 | ₹24.34 Cr | 2.70x |
| sNII ₹2–10 lakh | 3,63,000 | 2,31,000 | ₹2.86 Cr | 0.64x |
| Retail | 10,90,000 | 9,22,000 | ₹11.43 Cr | 0.85x |
| Total | 32,89,000 | 73,31,000 | ₹90.90 Cr | 2.23x |
* Shares Offered and Total Amount are calculated based on the upper price of the issue price range. * The portion of anchor investors (or market makers) is not included in the total number of shares offered.
Application-wise breakup and allotment chances
| Category | Lots reserved | Applications | Applied | Chance per application |
|---|---|---|---|---|
| QIB | — | 2 | — | — |
| NII | 363 | 222 | 0.61x | 1 in 1 |
| bNII | 242 | 167 | 0.69x | 1 in 1 |
| sNII | 121 | 55 | 0.45x | 1 in 1 |
| Retail | 545 | 461 | 0.85x | 1 in 1 |
"All valid" means applications are fewer than the lots reserved, so every valid application should get at least one lot. When applications exceed lots, allottees are picked by computerised lottery and "1 in X" is the rough chance for one application. The real chance is usually a little better: bids below the cut-off price and invalid applications are removed before the lottery.
Speciality Medicines IPO subscription day-wise
| Category | Day 3 |
|---|---|
| QIB | 96.24x |
| NII | 2.01x |
| bNII | 2.70x |
| sNII | 0.64x |
| Retail | 0.85x |
| Total | 2.23x |
| Total added | 2.23x |
Cumulative figures at the end of each day. Read across a row to see how demand built up. Shading deepens as subscription rises above 1x; "Total added" is how much overall subscription grew that day.
Speciality Medicines IPO reservation
| Category | Shares | Share of issue |
|---|---|---|
| Qualified Institutional Buyers | 21,000 | 0.95% |
| Non-Institutional Investors | 10,89,000 | 49.50% |
| bNII · above ₹10 lakh | 7,26,000 | 67% of NII |
| sNII · ₹2–10 lakh | 3,63,000 | 33% of NII |
| Retail Individual Investors | 10,90,000 | 49.55% |
| Public issue | 22,00,000 | 100% |
Allotment Chances Note
These are estimates from the latest application and subscription figures. Actual chances are usually somewhat better, because:
- Not every bid is at the cut-off price. Bids below the final issue price are rejected before the lottery, so fewer applications compete.
- Multiple-lot applications count once. In an oversubscribed retail or sNII portion, each application gets at most one minimum lot in the draw, however many lots it bid for.
- Invalid applications drop out. Unapproved UPI mandates, PAN mismatches and duplicate applications are removed before allotment.
Applying for more lots in the retail category does not improve your odds; applying from separate family accounts does.
Speciality Medicines IPO subscription: FAQs
- What is the overall subscription of Speciality Medicines IPO?
- Speciality Medicines IPO is subscribed 2.23x overall as of day 3 (24 March 2026), with bids for 73,31,000 shares against 32,89,000 offered.
- What is the retail subscription of Speciality Medicines IPO?
- The retail portion is subscribed 0.85x as of day 3 (24 March 2026). 461 retail applications have been received for 545 lots available.
- What is the QIB and NII subscription of Speciality Medicines IPO?
- QIBs have subscribed 96.24x of their portion, and NIIs 2.01x (bNII 2.70x, sNII 0.64x) as of day 3 (24 March 2026).
- What are the chances of getting Speciality Medicines IPO allotment?
- Retail applications are below the number of lots available, so every valid retail application is likely to receive at least one lot.
- How can I check Speciality Medicines IPO subscription status live?
- This page shows category-wise and day-wise figures and is updated during bidding hours. The same data is published on the BSE and NSE websites under the issue name.
- How do I apply for Speciality Medicines IPO?
- Apply online through your broker or bank using UPI or ASBA. Choose the IPO, enter the number of lots and bid price (retail investors can bid at the cut-off price), and approve the UPI mandate before the issue closes on 24 March 2026.
Subscription figures are compiled from BSE and NSE bid data and can be revised by the exchanges after the issue closes. For information only; not investment advice.